2STRADER DB,WRIGHT T,THOMAS DL. Diagnosis,management,and treatment of hepatitis C[J].{H}HEPATOLOGY,2004,(4):1147-1171. 被引量：1
3GHANY MG,STRADER DB,THOMAS DL. Diagnosis,management,and treatment of hepatitis C:Anupdate[J].{H}HEPATOLOGY,2009,(4):1335-1374. 被引量：1
4European Association for the Study of the Liver. EASL clinical practice guidelines:management of hepatitis C virus infection[J].{H}HEPATOLOGY,2011,(2):245-264. 被引量：1
5DONATrI T L, KOCH V H. Final height of adults with childhood-onset steroid-responsive idiopath nephrotic syn- drome[ J]. Pediatr Nephrol,2009 ,24(12) :2401 - 2408. 被引量：1
6MATSUKURA H, FUEHIZAWA T, HIGUCHI O, et al. Gross hematuria as an unusual manifestation in minimal change nephrotic syndrome [ J ]. Clin Nephrol, 2008,69 (2) :142 - 144. 被引量：1
7KODNER C. Nephrotic Syndrome in Adults:Diagnosis and Management[ J ]. Am Fam Physician, 2009, 80 ( 10 ) : 1129 - 1134. 被引量：1
8HODSON E M,WILLIS N S, CRAIG J C. Cortieosteroid therapy of nephrotic syndrome in children [ J ]. Cochrane Database Syst Rev, 2009,76(4) : 1333. 被引量：1
9BURTON C, HARRIS K P. The role of proteinurla in the progression of chronic renal failure [ J ]. Am J Kidney Dis, 1996,27(6) :765. 被引量：1
10ROVIN B H, TAN L C. LDL, stimulates mesangial ibronect ion production and chemoat tractant expression [ J ]. Kidney Int, 1993,43 ( 6 ) : 218. 被引量：1
